1534 related articles for article (PubMed ID: 30033891)
1. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
[TBL] [Abstract][Full Text] [Related]
2. Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.
González F
Steroids; 2012 Mar; 77(4):300-5. PubMed ID: 22178787
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in polycystic ovary syndrome.
Prelevic GM
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):193-201. PubMed ID: 9263704
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
[TBL] [Abstract][Full Text] [Related]
5. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
Azadi-Yazdi M; Karimi-Zarchi M; Salehi-Abargouei A; Fallahzadeh H; Nadjarzadeh A
J Hum Nutr Diet; 2017 Jun; 30(3):275-283. PubMed ID: 28466507
[TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome.
Shorakae S; Teede H; de Courten B; Lambert G; Boyle J; Moran LJ
Semin Reprod Med; 2015 Jul; 33(4):257-69. PubMed ID: 26132930
[TBL] [Abstract][Full Text] [Related]
7. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
8. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).
Barrea L; Arnone A; Annunziata G; Muscogiuri G; Laudisio D; Salzano C; Pugliese G; Colao A; Savastano S
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547562
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome.
Demi R İ; Guler A; Alarslan P; Isil AM; Ucman O; Aslanipour B; Calan M
Endocrine; 2019 Jul; 65(1):175-183. PubMed ID: 31154608
[TBL] [Abstract][Full Text] [Related]
10. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
Siddiqui S; Mateen S; Ahmad R; Moin S
J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
[TBL] [Abstract][Full Text] [Related]
11. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?
Morgante G; Troìa L; De Leo V
J Steroid Biochem Mol Biol; 2021 Jan; 205():105770. PubMed ID: 33065278
[TBL] [Abstract][Full Text] [Related]
13. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause.
Markopoulos MC; Valsamakis G; Kouskouni E; Boutsiadis A; Papassotiriou I; Creatsas G; Mastorakos G
Eur J Endocrinol; 2013 Jan; 168(1):83-90. PubMed ID: 23076844
[TBL] [Abstract][Full Text] [Related]
14. The interplay between androgens and the immune response in polycystic ovary syndrome.
Shabbir S; Khurram E; Moorthi VS; Eissa YTH; Kamal MA; Butler AE
J Transl Med; 2023 Apr; 21(1):259. PubMed ID: 37062827
[TBL] [Abstract][Full Text] [Related]
15. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
Tosi F; Dorizzi R; Castello R; Maffeis C; Spiazzi G; Zoppini G; Muggeo M; Moghetti P
Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review.
Di Lorenzo M; Cacciapuoti N; Lonardo MS; Nasti G; Gautiero C; Belfiore A; Guida B; Chiurazzi M
Curr Nutr Rep; 2023 Sep; 12(3):527-544. PubMed ID: 37213054
[TBL] [Abstract][Full Text] [Related]
17. Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome.
Perelman D; Coghlan N; Lamendola C; Carter S; Abbasi F; McLaughlin T
Gynecol Endocrinol; 2017 Apr; 33(4):324-327. PubMed ID: 27910718
[TBL] [Abstract][Full Text] [Related]
18. Free androgen index and Irisin in polycystic ovary syndrome.
Li H; Xu X; Wang X; Liao X; Li L; Yang G; Gao L
J Endocrinol Invest; 2016 May; 39(5):549-56. PubMed ID: 26584566
[TBL] [Abstract][Full Text] [Related]
19. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
20. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
